We think generic drugs always contribute to lower spending, but research in the Annals of Internal Medicine finds that generic drugs with a monopoly or in a duopoly have very large price increases, while those in more competitive markets see price declines.
http://annals.org/aim/article/2636750/high-generic-drug-prices-market-competition-retrospective-cohort-studyAltarum releases its first quarter 2017 health spending trend report.
Read More
A new AHRQ Statistical Brief describes where consumers get their usual medical care.
Read More
Enjoy the holiday and spend a few minutes contemplating what we celebrate.
Read More
Large drug company Roche (no relation, unfortunately) is playing the sugar daddy and sweetly acquiring diabetes logging app mySugr, giving its shareholders a rich payday. mySugr said its goal was to make diabetes suck less; I doubt the company did anything meaningful in that regard, but did get its shareholders a less sucky day.
http://medcitynews.com/2017/06/roche-acquires-mysugr/?_hsenc=p2ANqtz--L5_4mspEemPxPhKWLS20DJbg7lbxF0SdeBuRLJJrH_DcIK3RomlzHTU3M7hVEh5WnDV0h-eS9mh7LSqpsUQ0zP4-1m1g0XVyBf6JAQSTmNEfbGrs&_hsmi=53765476&rf=1A lot of nonsense is being tossed around about attempts to change the current federal health "reform" law.
Read More
Denied claims cost hospitals in lost revenue and rework, according to a study from Change Healthcare.
Read More